Previous 10 | Next 10 |
Aytu BioScience (NASDAQ: AYTU ) is set to join the Russell 3000 Index, effective after the close of the US markets on June 26. More news on: Aytu BioScience, Inc., Healthcare stocks news, Read more ...
ENGLEWOOD, CO / ACCESSWIRE / June 8, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company (the "Company") focused on commercializing novel products that address significant medical needs, is set to join the Russell 3000® Index at the conclusion of the 2020 Russ...
Natesto now covered as a Preferred Brand by leading national pharmacy benefits manager ENGLEWOOD, CO / ACCESSWIRE / June 3, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU) (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address significan...
Company Retires $15M Obligation Assumed with Previously Announced Cerecor Commercial Portfolio Asset Purchase Company's Debt Reduced to Approximately $1 Million ENGLEWOOD, CO / ACCESSWIRE / June 1, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company (the ...
Digital Ally (NASDAQ: DGLY ) +81% as Body-camera, surveillance stocks surge pre-market after protests . More news on: Digital Ally, Inc., Allied Esports Entertainment Inc., CTI BioPharma Corp., Stocks on the move, , Read more ...
US FDA OKs Aytu BioScience (NASDAQ: AYTU ) +15% emergency use authorization for the COVID-19 IgG/IgM rapid test cassette distributed by the Company. More news on: Aytu BioScience, Inc., Healthcare stocks news, Read more ...
Fourth FDA Emergency Use Authorization of a COVID-19 IgG/IgM Lateral Flow Rapid Test 1.4 Million Rapid Tests Available for Distribution at Company's Warehouse ENGLEWOOD, CO / ACCESSWIRE / June 1, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company (the "...
Cassava Sciences (NASDAQ: SAVA ) -82% after Alzheimer's candidate flunks mid-stage study. More news on: Cassava Sciences, Inc., Synthesis Energy Systems, Inc., Creative Realities, Inc., Stocks on the move, , Read more ...
Aytu BioScience, Inc. (AYTU) Q3 2020 Results Earnings Conference Call May 14, 2020, 04:30 PM ET Company Participants Joshua Disbrow - Chairman & CEO David Green - CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Presentation Operator Good afte...
Aytu BioScience (NASDAQ: AYTU ) fiscal Q3 results : More news on: Aytu BioScience, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Company receives proceeds of $3.5 million through exercise of warrants, a portion of which was used to pay down debt Interest rate on new $13.0 million term loan reduced by approximately 350 basis points today, potentially saving the Company $1.3 million over the life of the term loan T...
Phoenix, Arizona and New York, New York--(Newsfile Corp. - May 29, 2024) - Lytham Partners, a leading investor relations and corporate access firm, today announced the schedule for its Spring 2024 Investor Conference taking place virtually on May 30, 2024. More than 40 companies will be available...
DENVER, CO / ACCESSWIRE / May 23, 2024 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that Josh Disbrow, CEO, will participate in a webcasted fireside chat and host one-on-one meetings with inv...